Susquehanna International Group, LLP Deciphera Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$13.58 - $17.36 $320,718 - $409,991	-23,617 Reduced 28.9%	58,100 $913,000
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $92,931 - $152,035	9,192 Added 12.67%	81,717 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $248,165 - $308,315	19,917 Added 37.86%	72,525 $922,000
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $812,005 - $975,874	-61,145 Reduced 53.75%	52,608 $740,000
Q1 2023 May 16, 2023	BUY	$14.26 - $22.1 $1.24 Million - $1.92 Million	87,068 Added 326.28%	113,753 $1.76 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $667,032 - $855,238	-44,918 Reduced 62.73%	26,685 $437,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $745,907 - $1.22 Million	60,251 Added 530.75%	71,603 $1.33 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $1.29 Million - $1.98 Million	-141,764 Reduced 92.59%	11,352 $149,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $874,283 - $1.41 Million	-127,261 Reduced 45.39%	153,116 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $1.61 Million - $7.77 Million	209,362 Added 294.81%	280,377 $2.74 Million
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $60,434 - $84,850	-2,284 Reduced 3.12%	71,015 $2.41 Million
Q2 2021 Aug 11, 2021	BUY	$32.73 - $47.95 $1.53 Million - $2.24 Million	46,669 Added 175.25%	73,299 $2.68 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $900,575 - $1.26 Million	-22,297 Reduced 45.57%	26,630 $1.19 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $717,014 - $916,593	-13,850 Reduced 22.06%	48,927 $2.79 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $2.11 Million - $2.81 Million	48,232 Added 331.61%	62,777 $3.22 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $1.7 Million - $2.99 Million	-45,941 Reduced 75.95%	14,545 $869,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $708,415 - $1.46 Million	-21,065 Reduced 25.83%	60,486 $2.49 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $1.39 Million - $3.06 Million	43,734 Added 115.65%	81,551 $5.08 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $471,238 - $917,675	23,621 Added 166.39%	37,817 $1.28 Million
Q2 2019 Aug 16, 2019	BUY	$21.05 - $26.21 $109,354 - $136,160	5,195 Added 57.72%	14,196 $320,000
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $180,560 - $404,594	9,001 New	9,001 $354,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account